SCHEMBL1010572

SCHEMBL1010572

C=CCc1cccc(O)c1OC(C)(C)C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 2/20 0.46
GABRB2 P47870 2/20 0.46
AKR1B1 P15121 1/20 0.40
HSD17B10 Q99714 3/20 0.37
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
ALDH1A1 P00352 3/20 0.37
GAA P10253 2/20 0.37
MAPT P10636 2/20 0.37
KDM4E B2RXH2 2/20 0.37
CASP1 P29466 1/20 0.37
ADRA2A P08913 1/20 0.37
ADRA2B P18089 1/20 0.37
ADRA2C P18825 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.35
MAPK1 P28482 1/20 0.35
POLB P06746 1/20 0.34
CYP3A4 P08684 1/20 0.34
ALOX5 P09917 1/20 0.34
AR P10275 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5547437 0.82 GABRA1 (0.40) GABRA1GABRB2AKR1B1HSD17B10MEN1
SCHEMBL3739900 0.81 GABRA1 (0.50) GABRA1GABRB2AKR1B1HSD17B10MEN1
SCHEMBL6672329 0.79 GABRA1 (0.47) GABRA1GABRB2AKR1B1HSD17B10MEN1
SCHEMBL9240445 0.77 GABRA1 (0.54) GABRA1GABRB2AKR1B1MEN1KMT2A
SCHEMBL4871845 0.75 GABRA1 (0.50) GABRA1GABRB2AKR1B1HSD17B10MEN1
SCHEMBL175552 0.74 GABRA1 (0.46) GABRA1GABRB2AKR1B1HSD17B10MEN1
SCHEMBL28869658 0.74 CNR1 (0.43) GABRA1GABRB2HSD17B10MEN1KMT2A
Chavicol SCHEMBL6450748 0.73 ALDH1A1 (0.47) GABRA1GABRB2AKR1B1MEN1KMT2A
SCHEMBL7984311 0.73 ALDH1A1 (0.47) ALDH1A1KDM4EADRA2AADRA2BADRA2C
2-Allylphenol SCHEMBL11780118 0.72 GABRA1 (0.50) GABRA1GABRB2AKR1B1ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260001986-A1 THERMOPLASTIC COMPOSITION FOR LASER DIRECT STRUCTURING MCE TECHNICAL CENTER B V (NL) 2026-01-01 US disclosed
EP-4551652-A1 THERMOPLASTIC COMPOSITION FOR LASER DIRECT STRUCTURING MCE Technical Center B.V. (NL) 2025-05-14 EP disclosed
CN-119562991-A Thermoplastic composition for laser direct structuring MCE技术中心有限公司 2025-03-04 CN disclosed
WO-2024008786-A1 THERMOPLASTIC COMPOSITION FOR LASER DIRECT STRUCTURING MEP EUROPE B.V. (NL) 2024-01-11 WO disclosed
EP-4303269-A1 THERMOPLASTIC COMPOSITION FOR LASER DIRECT STRUCTURING MEP Europe B.V. (NL) 2024-01-10 EP disclosed
EP-3500628-B1 THERMOPLASTIC COMPOSITION FOR LASER DIRECT STRUCTURING MEP EUROPE B V (NL) 2020-12-09 EP disclosed
EP-3500628-A1 THERMOPLASTIC COMPOSITION FOR LASER DIRECT STRUCTURING MEP Europe B.V. (NL) 2019-06-26 EP disclosed
CN-109790364-A THERMOPLASTIC COMPOSITION FOR LASER DIRECT STRUCTURING MEP欧洲有限公司 2019-05-21 CN disclosed
CN-106132702-B Multi-layer sheet, manufacturing method and the product formed by it 沙特基础工业全球技术有限公司 2019-02-15 CN disclosed
EP-2935408-B1 THERMOPLASTIC COMPOSITION MITSUBISHI CHEMICAL EUROPE GMBH (DE) 2017-11-29 EP disclosed
EP-2935408-A1 THERMOPLASTIC COMPOSITION Mitsubishi Chemical Europe GmbH (DE) 2015-10-28 EP disclosed
WO-2014095648-A1 THERMOPLASTIC COMPOSITION MITSUBISHI CHEMICAL EUROPE GMBH (DE) 2014-06-26 WO disclosed
EP-2746316-A1 Thermoplastic composition Mitsubishi Chemical Europe GmbH (DE) 2014-06-25 EP disclosed
EP-2342281-A1 FLAME RETARDANT THERMOPLASTIC POLYMER COMPOSITION, METHOD OF MANUFACTURE, AND ARTICLES FORMED THEREFROM SABIC Innovative Plastics IP B.V. (NL) 2011-07-13 EP disclosed
EP-2268703-A1 PROCESSES FOR PREPARING POLYESTERCARBONATES SABIC Innovative Plastics IP B.V. (NL) 2011-01-05 EP disclosed
EP-2203520-A1 POLYCARBONATE COMPOSITION HAVING IMPROVED IMPACT, FLAMMABILITY AND SURFACE APPEARANCE, METHOD OF MAKING, AND ARTICLES PREPARED THEREFROM Sabic Innovative Plastics IP B.V. (NL) 2010-07-07 EP disclosed
WO-2010036900-A1 FLAME RETARDANT THERMOPLASTIC POLYMER COMPOSITION, METHOD OF MANUFACTURE, AND ARTICLES FORMED THEREFROM SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2010-04-01 WO disclosed
WO-2009126549-A1 PROCESSES FOR PREPARING POLYESTERCARBONATES SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2009-10-15 WO disclosed
WO-2009040772-A1 POLYCARBONATE COMPOSITION HAVING IMPROVED IMPACT, FLAMMABILITY AND SURFACE APPEARANCE, METHOD OF MAKING, AND ARTICLES PREPARED THEREFROM SABIC INNOVATIVE PLASTICS IP B.V. (US) 2009-04-02 WO disclosed
WO-2009042755-A1 COPOLYCARBONATE COMPOSITIONS SABIC INNOVATIVE PLASTICS I.P. B.V. (NL) 2009-04-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260001986-A1 THERMOPLASTIC COMPOSITION FOR LASER DIRECT STRUCTURING DYNLL2, PUM2, DYNLL1 GABRA1 1768/4885GABRB2 997/4885AKR1B1 3497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.